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Abstract
Objective—To describe associations among maternal lipids and birthweight and to determine 
whether pre-pregnancy body mass index (BMI) modifies these associations.
Design—Cohort Study.
Setting—Multiple communities in Michigan, USA.
Population—Participants were a sub-cohort of women from the multi-community Pregnancy 
Outcomes and Community Health (POUCH) study (1998–2004).
Methods—Maternal total cholesterol, high-density lipoprotein (HDLc), and low-density 
lipoprotein (LDLc) cholesterol, and triglycerides were assessed at 16–27 weeks’ gestation. 
Women were classified as having normal (<25 kg/m2) or overweight/obese (≥25 kg/m2) pre-
pregnancy BMI.
Main Outcome Measures—Sex- and gestational-age-specific BWz-score.
Results—Regression models examined associations among lipids (low: 1st quartile, referent: 
middle quartiles, high: 4th quartile) and BWz-scores for the total sample and stratified by pre-
pregnancy BMI. In adjusted analyses (n=1207), low HDLc was associated with lower BWz-score 
(β=−0.23, 95%CI: −0.40 to −0.06) while high triglycerides was associated with higher BWz-score 
(β=0.23, 95%CI: 0.06–0.41). Once stratified by pre-pregnancy BMI, low total cholesterol was 
associated with lower BWz-score in normal BMI women (β= −0.25, 95%CI: −0.47 to −0.03), 
while in overweight/obese BMI women, high HDLc was inversely (β= −0.29, 95%CI: −0.54 to 
−0.04) and high triglycerides was directly associated with BWz-score (β=0.32, 95%CI: 0.07– 
0.54). Removing women with gestational diabetes/hypertensive disorders did not alter the results.
Conclusions—The associations among maternal lipids and BWz-score vary by lipid measure 
and pre-pregnancy BMI. Future work should examine whether lipids and pre-pregnancy BMI 
make unique contributions to the fetal programming of disease.
Corresponding Author: Lanay M. Mudd, Department of Kinesiology, Michigan State University, 308 West Circle Drive, East 
Lansing, MI 48824, USA, mudd@msu.edu. 
Conflicts of Interest
The authors report no conflicts of interest.
HHS Public Access
Author manuscript
Acta Obstet Gynecol Scand. Author manuscript; available in PMC 2016 August 01.
Published in final edited form as:














cholesterol; triglycerides; fetal programming; obesity; fetal growth
Introduction
Maternal lipids during pregnancy are known to increase as part of a normal physiological 
response to pregnancy, despite hemodilution (1). Increased lipid levels contribute towards 
hormonal and nutritional support of a healthy pregnancy (2); nevertheless, extremely high 
levels may induce oxidative stress and have been linked to poorer birth outcomes in animal 
models (3) and to atherosclerosis in human offspring (4). In contrast, low lipid levels may 
reflect an inadequate response to pregnancy and have been associated with preterm delivery 
and lower birthweight (BW) (5).
Previous investigations on associations among maternal lipid profiles and BW have shown 
that higher triglyceride (TG) levels are related to higher BW and/or increased risk of 
macrosomia, especially among women with gestational diabetes or a positive diabetic screen 
(6–11). In addition to TG, increasing low-density-lipoprotein cholesterol (LDLc) levels have 
been associated with increased odds for macrosomia, while increasing high-density-
lipoprotein cholesterol (HDLc) levels decreased these odds (9). On the other end of the BW 
distribution, intrauterine growth restriction has been associated with lower levels of total 
cholesterol (TC) and/or LDLc (12, 13).
It has recently been suggested that maternal obesity may influence associations among 
maternal lipids and fetal development. Misra et. al.(14) showed that HDLc levels measured 
at multiple times throughout pregnancy were inversely associated with BW, but only among 
women with overweight/obese pre-pregnancy body mass index (BMI) (i.e. BMI ≥ 25 
kg/m2). They also showed that while BW was directly related to TG measured at early (10–
14 weeks) and mid- gestation (22–26 weeks) among normal weight women, TG was only 
significantly related to BW among overweight/obese women when measured in mid to late 
pregnancy (22–26 and 32–36 weeks). These results suggest that maternal BMI status may 
alter maternal metabolic factors during pregnancy leading to changes in fetal development; 
however, they are based on a fairly small (n=142) and homogeneous sample of women (14).
The aim of this study was to determine whether levels of maternal TC, HDLc, LDLc, or TG 
measured at mid-pregnancy were associated with sex- and gestational-age-specific BW 
standard scores (BWz) in a large and diverse sample of women. Secondly, we sought to 
determine whether maternal pre-pregnancy BMI status modified associations among 
maternal lipids and BW.
Material and methods
Data from the Pregnancy Outcomes and Community Health (POUCH) Study were used to 
evaluate the aims. The POUCH study was primarily designed to investigate preterm delivery 
and has been previously described (15). Briefly, pregnant women were recruited from 52 
clinics in five Michigan communities from 1998–2004, and enrolled during their 16th–27th 
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week of pregnancy (15). Eligibility criteria included singleton pregnancy with no known 
chromosomal abnormality or birth defect, screening for maternal serum alpha-fetoprotein 
(MSAFP), maternal age ≥ 15 years, no pre-existing diabetes mellitus, and proficiency in 
English. All women with high MSAFP levels (i.e. ≥ 2 multiples of the mean) were invited to 
participate because this biomarker has been previously associated with preterm delivery. 
Women with normal MSAFP levels were stratified by race/ethnicity and randomly sampled 
into the cohort. Institutional review boards at Michigan State University, the Michigan 
Department of Community Health, and nine community hospitals, which collectively 
covered all study clinics, approved the study.
The POUCH study enrolled 3038 women, and accomplished delivery follow-up for 3019 
women. A sub-cohort of women (n=1371) was selected to maximize resources for more 
detailed study (such as biomarker assays, placental pathology) and to permit sub-analyses of 
strata of particular interest. The sub-cohort included all women who delivered preterm (<37 
weeks), women who delivered at term but had high MSAFP levels, and a race-stratified 
sample of women with term deliveries and normal MSAFP levels, with oversampling of the 
African-American stratum. All analyses were weighted according to the probabilities of 
selection into the cohort and sub-cohort to remove bias due to oversampling from certain 
strata. Stored blood samples from 62 women in the sub-cohort lacked enough blood for lipid 
analyses and an additional 102 women lacked data on pre-pregnancy BMI or gestational 
weight gain, thus the final sample for this study included 1,207 women (88% of the 
subcohort).
At enrollment, women signed consent forms, completed self-administered surveys and in-
person interviews with a study nurse, and had a non-fasting venous blood draw. Prenatal and 
labor and delivery records were abstracted. Gestational age was calculated using the last 
menstrual period unless it disagreed by more than two weeks with ultrasound conducted 
prior to 25 weeks gestation, in which case the ultrasound value was used. Thus, the last 
menstrual period estimate was used in 76% of the cohort where the two estimates agreed and 
in 6% of the cohort where only last menstrual period estimates were available. Ultrasound 
estimates were used in the remaining 18% of the cohort with absent or conflicting last 
menstrual period estimates. Sex-and gestational-age specific BWz-scores were calculated 
using means and standard deviations from a reference population (16).
Measurement of blood lipids
Non-fasting blood samples were drawn at a mean gestational age of 22.4 weeks (range: 15–
27 wks), centrifuged within 45 minutes of collection, aliquoted (1 ml), and stored at -80°C 
until analyses. Samples were shipped on dry ice to the Nutrition Lab in the Department of 
Epidemiology at the University of Pittsburgh for lipid analyses. This laboratory has been 
included in the Centers for Disease Control and Prevention – National Heart, Lung and 
Blood Institute (CDC-NHLBI) Lipid Standardization Program since 1982, is Clinical 
Laboratory Improvement Act (CLIA) certified and participates in College of American 
Pathologists proficiency programs. TC (mmol/L) was determined using the enzymatic 
method of Allain et al.(17). HDLc (mmol/L) was measured directly using a homogeneous 
two-reagent method with materials obtained from Equal Diagnostics. LDLc (mmol/L) was 
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calculated indirectly using the Friedewald equation: , except 
when total TG exceeded 4.52 mmol/L, in which case LDLc was measured directly using an 
automated spectrophotmetric assay (LDL Direct Liquid Select) from Equal Diagnostics (18). 
TG (mmol/L) were determined enzymatically using the Bucolo et. al. procedure (19). 
Duplicate samples with standards, control sera and serum calibrators were included in each 
run. The coefficients of variation ranged from 1.3 to 6.7%.
Covariates
The enrollment interview and questionnaire provided information on demographics, medical 
and reproductive history, pre-pregnancy weight and height (BMI calculated, kg/m2), and 
smoking and alcohol intake during pregnancy. For stratified analyses, women were 
classified as having normal (<25 kg/m2) or overweight/obese (≥25 kg/m2) pre-pregnancy 
BMI. Maternal weight at the time of the blood draw was recorded. Medical record 
abstraction provided information on gestational weight gain and data for identifying 
hypertensive disorders and gestational diabetes. Women were classified as having low, 
recommended or high gestational weight gain based on the pre-pregnancy BMI according to 
the 2009 Institute of Medicine guidelines (20).
Statistical analyses
Analyses were conducted with SAS version 9.3 (SAS Institute, Cary, NC, USA). Statistical 
significance was set at a two-sided alpha level of p<0.05. Sampling weights were used to 
remove bias due to oversampling of high MSAFP into the cohort and oversampling of high 
MSAFP, preterm deliveries, and African Americans into the subcohort. Thus, weighted 
results account for the POUCH sampling scheme and should reflect the experience of the 
population of pregnant women that was initially sampled.
Descriptive statistics of participant characteristics were calculated for the total sample and 
for each stratum of pre-pregnancy BMI. Chi-squared and Student’s t-test analyses were used 
to test for significant differences in participant characteristics by pre-pregnancy BMI. 
Because lipid values were skewed, log-transformed values (which normalized lipid 
distributions) were used when calculating mean levels, which were then back-transformed 
for reporting.
Previous evidence suggests that extreme lipids levels, too low or too high, may mark 
adverse pregnancy outcomes (21), and therefore our statistical modeling strategy was 
designed to detect threshold and U-shaped effects. We chose, beforehand, a quartile 
distribution and categorized women as having low (<25th percentile), referent (25-<75th 
percentile) or high (≥75th percentile) TC, HDLc, LDLc and TG values. To calculate cut 
points, we used the normalized log-transformed lipid distributions among women with 
normal MSAFP values who delivered at term (i.e. healthy pregnancies). Cut points for low 
and high lipid categorizations, respectively, were <5.12 mmol/L and ≥6.59 mmol/L for TC, 
<1.50 mmol/L and ≥2.04 mmol/L for HDLc, <2.04 mmol/L and ≥2.53 mmol/L for LDLc, 
and <1.54 mmol/L and ≥2.45 mmol/L for TG (all values back-transformed from the natural 
log scale). Unadjusted and adjusted regression models were used to evaluate whether low or 
high lipid values were associated with mean BWz-score. Since lipid values increase with 
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gestational week and African Americans are known to have more favorable lipid profiles 
than Whites, gestational week at the time of blood draw (continuous) and race (White/
Others vs. African American) were considered as covariates in all adjusted models (22, 23). 
Based on previous publications the following covariates were also considered: parity, pre-
pregnancy BMI, maternal weight at blood draw, Medicaid insurance status, marital status, 
education level, age, smoking, and alcohol use during pregnancy. Medicaid insurance status 
was used a marker of low income as this insurance is only available to pregnant women in 
the USA who meet eligibility criteria based on federal poverty levels. Any variable that 
altered estimates of associations between lipid levels and BWz-score by more than 10% was 
retained in the adjusted models. Gestational weight gain poses a special challenge in these 
models, as it could be a confounder, mediator, or collider variable. Thus we decided to 
compare models with and without this covariate and interpret differences cautiously. In a 
second set of adjusted models, women with gestational diabetes or hypertensive disorders 
were removed from the analytic sample to determine whether their absence changed 
parameter estimates for associations among lipids and BWz-score.
Finally, in order to determine whether pre-pregnancy BMI was an effect modifier, formal 
tests for interaction between pre-pregnancy BMI and each lipid were examined. Significant 
interaction terms were observed for every lipid except triglycerides, therefore all of the 
above analyses were repeated within the two strata of normal and overweight/obese pre-
pregnancy BMI.
Results
The weighted sample estimates show that our cohort was diverse with 25% African 
American women and 49% of the women enrolled in Medicaid Insurance (Table 1). Half of 
all participants were overweight/obese pre-pregnancy. Women with normal pre-pregnancy 
BMI were significantly more likely to have gestational weight gain within the recommended 
range, be younger, have more than a high school education, not be enrolled in Medicaid 
insurance, be White/Other race, be nulliparous, and not be diagnosed with gestational 
diabetes or hypertensive disorders when compared to women with overweight/obese pre-
pregnancy BMI (Table 1). Mean BW was 3340 g (95%CI: 3.31 – 3.38) corresponding to a 
mean sex- and gestational-age-specific BWz-score of 0.06 (95%CI: −0.01 to − 0.13) (Table 
2). Mean lipid values for the total group were similar to those previously reported for second 
trimester measurements (1). Women with normal pre-pregnancy BMI had significantly 
lower mean BWz-score and TG values and significantly higher HDLc values compared to 
women with overweight/obese pre-pregnancy BMI (Table 2).
Within the total sample of women, low HDLc was related to significantly lower BWz-score 
(β= −0.23, 95% CI: −0.40 to −0.06), while high TG was related to significantly higher BWz-
score (β=0.23, 95% CI: 0.06 – 0.41) after adjustment for maternal race, pre-pregnancy BMI, 
gestational smoking, parity, age and gestational age at time of blood draw (Table 3). Further 
adjustment for gestational weight gain did not alter associations between lipids and BWz-
score, thus we have left this variable out of all adjusted models due to concerns that it may 
be in the causal pathway. In stratified analyses, low TC (β= −0.25, 95%CI: −0.47 to −0.03) 
was related to significantly lower BWz-score among women with normal pre-pregnancy 
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BMI (Table 4). In contrast, among overweight/obese women, high HDLc was related to 
significantly lower BWz-score (β= −0.29, 95% CI: −0.54 to −0.04) and high TG was related 
to significantly higher BWz-score (β=0.31, 95% CI: 0.07 – 0.54). Stratified analyses were 
adjusted for maternal race, gestational smoking, parity, age, and gestational age at blood 
draw. Removal of women with gestational diabetes (n=61) or hypertensive conditions 
(n=132) did not significantly alter any results (data not shown).
Discussion
Our results showed that the associations among maternal lipids and mean BWz-score varied 
by lipid measure and pre-pregnancy BMI. Both HDLc and TG levels were related to BW z-
score among overweight/obese women, while BWz-score was related to TC among normal 
weight women. These findings are not explained by pregnancy complications such as 
diabetes or hypertension as removal of women with these conditions did not alter results. In 
the instances where significant associations were found, the beta estimates from adjusted 
analyses indicated that having low or high lipid levels may impact BW by 0.2–0.4 z-score 
units. This represents a magnitude of effect of approximately ± 225 g to 300 g for an infant 
born at term, which could translate into a clinically significant change in BW.
Previous research has shown that lower levels of TC were associated with decreased BW 
and/or intrauterine growth restriction/small-for-gestational age BW (5, 12, 13). However, 
results with low HDLc and lower BW are less conclusive with some not considering HDLc 
(5) and others reporting no significant associations (12). One study among 625 Greek 
women did find that HDLc levels <50 mg/dl (<1.29 mmol/L) significantly increased odds of 
small-for-gestational age BW (13). It is important to note that studies on lipids and low BW 
have involved small samples (n=16 – 100) which may have limited their ability to detect 
associations among HDLc and BW. On the other end of the BW distribution, similar to our 
results in the total (non-stratified) sample, several studies have also documented associations 
between high TG levels and higher BW and/or macrosomia (6–11). Most of these previous 
studies were in the context of gestational diabetes or impaired glucose tolerance. Thus it is 
important that we found a similar association among a large sample of predominantly non-
diabetic women, and the association was not altered by excluding women with gestational 
diabetes or hypertensive disorders.
From a biological perspective, it is reasonable to expect that either high or low levels of 
maternal lipids may affect fetal growth. Triglycerides and free fatty acids directly support 
fetal growth (2). Throughout pregnancy, placental enzymes hydrolyze LDL and HDL 
releasing free fatty acids and glycerol which are taken up by trophoblast cells and re-
esterified to provide a fat reservoir for the developing fetus (24). There is also evidence that 
increased maternal lipid levels late in pregnancy allows the woman to spare blood glucose 
for the fetus, thereby promoting fetal growth (24).
Maternal obesity may impact the maternal metabolic milieu and fetal development (25). It 
was recently shown that pre-pregnancy BMI altered the trajectory of lipid changes 
throughout pregnancy (26). Specifically, women with overweight/obese pre-pregnancy BMI 
had consistently higher TG levels compared to normal weight women, but had a slower rate 
Mudd et al. Page 6













of change in TC and LDLc over pregnancy resulting in significantly lower levels of these 
lipids in the third trimester (26). These results may indicate a dysregulation of the metabolic 
response to pregnancy among overweight/obese women. In our sample, mid-pregnancy 
levels of TG were significantly higher and HDLc were significantly lower among women 
with overweight/obese pre-pregnancy BMI compared to normal weight women, while there 
were no significant differences in TC and LDLc levels. It is possible that our lipids were 
measured too early in pregnancy to see differences in TC and LDLc levels caused by the 
slower rate in change among overweight women.
Misra et al.(14) is the only previous study to consider associations among lipids and BW 
stratified by pre-pregnancy BMI, as we have done. Their study involved 143 predominantly 
white, middle class women (72 normal weight and 71 overweight/obese) and measured 
lipids at five time-points during pregnancy. Their findings showed that among normal 
weight women, higher BW was related to increasing TG measured at 10–14 weeks or 22–26 
weeks gestation. No other lipid measurement was related to BW among normal weight 
women. In contrast, among overweight/obese women, TG measured at 22–26 or 32–36 
weeks was related to higher BW, while increasing HDLc measured anytime after 10 weeks 
gestational was related to lower BW (14). Our lipids were measured only once at 16–27 
weeks of gestation (mean gestational age of blood draw = 22.4 weeks). Our results for 
women with overweight/obese pre-pregnancy BMI were similar to those of Misra et al for 
the 22–26 week time-frame (14). However, our results for normal weight women were 
somewhat different. We saw no significant associations among TG and BWz-score among 
normal weight women, but instead found that low TC was related to significantly lower 
BWz-score. The POUCH study included a much larger sample of women with greater 
diversity, thus it is possible that differences in results reflect greater power to detect 
associations after controlling for various covariates.
Our finding of effect modification by pre-pregnancy BMI suggests maternal adiposity may 
alter the metabolic response to pregnancy and/or the fetal growth response to the maternal 
metabolic milieu. Maternal obesity may also alter placental function and/or substrate 
delivery leading to differences in observed associations among specific lipids and BWz-
score (27). Future studies to elucidate the mechanisms at play are needed as interventions to 
improve the maternal metabolic profile during pregnancy may be a useful strategy for 
normalizing BW in the future.
Some limitations should be noted. Similar to most previous studies, we measured lipids only 
once during pregnancy (5–13), thus we were unable to determine if associations among 
lipids and BWz-score differed across pregnancy as Misra et al explored (14). We also 
measured lipids in the non-fasted state, similar to some previous investigations (9, 11). 
While fasting measures would be preferred, these are often difficult to accomplish during 
pregnancy. Studies comparing fasting versus non-fasting lipid levels show minimal 
differences (<5%) for TC, HDLc, and LDLc values, while TG are ~15% higher in the non-
fasted state (28, 29). Since we used the Friedewald equation to calculate LDLc based on TG, 
our LDLc values likely reflect greater variation from fasting values as well. Extra variation 
induced by using non-fasted lipid levels should affect all women similarly without regard to 
BW and thus have a non-differential effect, most likely attenuating results. Further, results 
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from population based studies suggest that non-fasting TG values likely represent remnant 
lipoproteins and are strongly predictive of adverse events including myocardial infarction 
and stroke (30). The authors of these reports propose that future clinical care could be 
simplified by using non-fasting lipid profiles for risk prediction, especially as we spend the 
majority of our time in the non-fasting state. Our use of internal cut points to define the 
lowest and highest quartiles of lipids may not be generalizable to other populations; 
however, we did define the cut points using a low risk obstetric sample (i.e. normal MSAFP, 
no pre-pregnancy diabetes, term delivery) and healthy ranges for lipids have yet to be 
established during pregnancy. Results from our study and similar studies on maternal lipid 
levels and fetal growth in high income countries may not apply to circumstances of low 
income countries with severe under-nutrition. Finally, in our sample and others, the causal 
ordering is uncertain as fetal and/or placental irregularities may influence maternal lipid 
levels and visa versa. Effect modification by maternal pre-pregnancy BMI argues that at 
least some of the effect begins with the mother.
Despite these limitations, our results add to the existing literature on maternal lipids and 
BW. The POUCH study provided a relatively large and diverse sample which allowed us to 
control for important covariates. Thus we were able to expand on the results reported by 
Misra et al.(14), showing differing associations among lipids and BW based on pre-
pregnancy BMI. We were also able to examine TC, HDLc, LDLc, and TG individually in 
relation to BW, rather than being limited to only one or two of these lipids as some previous 
reports. Finally, unlike previous investigations that focused on women with gestational 
diabetes and/or impaired glucose tolerance, we were able to document associations among 
lipids and BW among a mostly healthy pregnant population, and these associations persisted 
after removing women with diagnoses of gestational diabetes or hypertensive disorders.
Conclusions
Our results indicate that maternal lipid levels at mid-pregnancy may be related to fetal 
growth among non-diabetic women, and that maternal obesity may alter associations for 
lipids and BW. Future studies with multiple prospective measures of lipids are needed to 
determine the most biologically relevant window for measuring maternal lipids in relation to 
birth outcomes. It is possible that alterations in lipid metabolism and transfer are part of the 
biological pathway linking maternal obesity to poor birth outcomes (such as extreme BW 
valuers) as well as fetal programming of later chronic disease (4, 25, 27). Thus, mechanistic 
studies are needed to elucidate how maternal obesity may alter maternal lipid production, 
placental transfer of lipids, and/or fetal response to lipids.
Acknowledgments
The authors thank the community research study nurses for careful data collection and Bertha Bullen for her role in 
study logistics and data management.
Funding
This work was supported by the Perinatal Epidemiological Research Initiative Program Grant from the March of 
Dimes Foundation (Grants 20FY01-38 and 20-FY04-37); the National Institute of Child Health and Development 
and National Institute of Nursing Research (Grant R01 HD34543); the Thrasher Research Foundation (Grant 
02816-7); and the Centers for Disease Control and Prevention (Grant U01 DP000143-01). LMM was supported by 
Mudd et al. Page 8













the Building Interdisciplinary Careers in Women’s Health award from the Office of Women’s Health Research 
(K12HD065879-03).
Abbreviations
BMI body mass index
BW birthweight
BWz birthweight standard score
HDLc high-density lipoprotein cholesterol
LDLc low-density lipoprotein cholesterol
MSAFP maternal serum alpha-fetoprotein




1. Basaran A. Pregnancy-induced hyperlipoproteinemia: Review of the literature. Reprod Sci. 2009; 
16:431–7. [PubMed: 19233944] 
2. Herrera E. Lipid metabolism in pregnancy and its consequences in the fetus and newborn. 
Endocrine. 2002; 19:43–55. [PubMed: 12583601] 
3. De Assis SMA, Seguro AC, Helon CMB. Effects of maternal hypercholesterolemia on pregnancy 
and development of offspring. Pediatr Nephrol. 2003; 18:328–34. [PubMed: 12700957] 
4. Napoli C, D’Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, et al. Fatty streak 
formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. 
Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment 
into early atherosclerotic lesions. J Clin Invest. 1997; 100:2680–90. [PubMed: 9389731] 
5. Edison RJ, Berg K, Remaley A, Kelley R, Rotimi C, Stevenson RE, et al. Adverse birth outcome 
among mothers with low serum cholesterol. Pediatrics. 2007; 120:723–33. [PubMed: 17908758] 
6. Kushtagi P, Arvapally S. Maternal mid-pregnancy serum triglyceride levels and neonatal birth 
weight. Int J Gynaecol Obstet. 2009; 106:258–9. [PubMed: 19327771] 
7. Di Cianni G, Miccoli R, Volpe L, Lencioni C, Ghio A, Giovannitti MG, et al. Maternal triglyceride 
levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med. 2005; 
22:21–5. [PubMed: 15606686] 
8. Son GH, Kwon JY, Kim YH, Park YW. Maternal serum triglycerides as predictive factors for large-
for-gestational age newborns in women with gestational diabetes mellitus. Acta Obstet Gynecol 
Scand. 2010; 89:700–4. [PubMed: 20423280] 
9. Clausen T, Burski TK, Oyen N, Godang K, Bollerslev J, Henriksen T. Maternal anthropometric and 
metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term 
pregnancies. A prospective study. Eur J Endocrinol. 2005; 153:887–94. [PubMed: 16322395] 
10. Schaefer-Graf UM, Graf K, Kulbacka I, Kjos SL, Dudenhausen J, Vetter K, et al. Maternal lipids 
as strong determinants of fetal environment and growth in pregnancies with gestational diabetes 
mellitus. Diabetes Care. 2008; 31:1858–63. [PubMed: 18606978] 
11. Vrijkotte TG, Algera SJ, Brouwer IA, van Eijsden M, Twickler MB. Maternal triglyceride levels 
during early pregnancy are associated with birth weight and postnatal growth. J Pediatr. 2011; 
159:736–42. [PubMed: 21705016] 
Mudd et al. Page 9













12. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Divergent metabolic and 
vascular phenotypes in pre-eclampsia and intrauterine growth restriction: Relevance of adiposity. J 
Hypertens. 2004; 22:2177–83. [PubMed: 15480103] 
13. Chatzi L, Plana E, Daraki V, Karakosta P, Alegkakis D, Tsatsanis C, et al. Metabolic syndrome in 
early pregnancy and risk of preterm birth. Am J Epidemiol. 2009; 170:829–36. [PubMed: 
19713286] 
14. Misra VK, Trudeau S, Perni U. Maternal serum lipids during pregnancy and infant birth weight: 
The influence of prepregnancy BMI. Obesity (Silver Spring). 2011; 19:1476–81. [PubMed: 
21394096] 
15. Holzman C, Bullen B, Fisher R, Paneth N, Reuss L. Pregnancy outcomes and community health: 
The POUCH study of preterm delivery. Paediatr Perinat Epidemiol. 2001; 15 (Suppl 2):136–58. 
[PubMed: 11520406] 
16. Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A, Abrahamowicz M, et al. A new and 
improved population-based Canadian reference for birth weight for gestational age. Pediatrics. 
2001; 108:E35. [PubMed: 11483845] 
17. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum 
cholesterol. Clin Chem. 1974; 20:470–5. [PubMed: 4818200] 
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density 
lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 
18:499–502. [PubMed: 4337382] 
19. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin 
Chem. 1973; 19:476–82. [PubMed: 4703655] 
20. Rasmussen KM, Catalano PM, Yaktine AL. New guidelines for weight gain during pregnancy: 
What obstetrician/gynecologists should know. Curr Opin Obstet Gynecol. 2009; 21:521–6. 
[PubMed: 19809317] 
21. Mudd LM, Holzman CB, Catov JM, Senagore PK, Evans RW. Maternal lipids at mid-pregnancy 
and the risk of preterm delivery. Acta Obstet Gynecol Scand. 2012; 91:726–35. [PubMed: 
22404756] 
22. Ford ES, Li C, Pearson WS, Zhao G, Mokdad AH. Trends in hypercholesterolemia, treatment and 
control among United States adults. Int J Cardiol. 2010; 140:226–35. [PubMed: 19081646] 
23. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and 
awareness, treatment, and control of hypercholesterolemia among us adults: Findings from the 
National Health And Nutrition Examination Survey, 1999 to 2000. Circulation. 2003; 107:2185–9. 
[PubMed: 12719276] 
24. von Versen-Hoeynck FM, Powers RW. Maternal-fetal metabolism in normal pregnancy and 
preeclampsia. Front Biosci. 2007; 12:2457–70. [PubMed: 17127255] 
25. Catalano PM, Ehrenberg HM. The short- and long-term implications of maternal obesity on the 
mother and her offspring. BJOG. 2006; 113:1126–33. [PubMed: 16827826] 
26. Vahratian A, Misra VK, Trudeau S, Misra DP. Prepregnancy body mass index and gestational age-
dependent changes in lipid levels during pregnancy. Obstet Gynecol. 2010; 116:107–13. [PubMed: 
20567175] 
27. King JC. Maternal obesity, metabolism, and pregnancy outcomes. Annu Rev Nutr. 2006; 26:271–
91. [PubMed: 16704347] 
28. Mora S, Rifai N, Buring JE, Ridker PM. Fasting compared with nonfasting lipids and 
apolipoproteins for predicting incident cardiovascular events. Circulation. 2008; 118:993–1001. 
[PubMed: 18711012] 
29. Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: Influence of normal 
food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 
2008; 118:2047–56. [PubMed: 18955664] 
30. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of 
myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007; 
298:299–308. [PubMed: 17635890] 
Mudd et al. Page 10














Within a large, diverse cohort maternal lipid levels at mid-pregnancy appear to influence 
fetal growth. Pre-pregnancy body mass index modifies the associations between maternal 
lipids and birthweight, even when adjusting for covariates or excluding women with 
gestational diabetes or hypertensive disorders.
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Table 1











 Low 194 (14.4) 77 (9.7) 117 (19.4)
 Recommended 274 (23.3) 183 (31.0) 91 (15.1) <0.001*
 High 739 (62.3) 342 (59.3) 397 (65.5)
Maternal age (years)
 <20 185 (12.9) 118 (17.1) 67 (8.5)
 20-<30 693 (57.5) 317 (52.5) 376 (62.6) <0.001*
 30+ 329 (29.7) 167 (30.4) 162 (28.8)
Maternal education
 < High School 280 (19.4) 148 (20.3) 132 (18.5)
 High School/GED 334 (26.2) 143 (22.6) 191 (30.0) 0.047*
 > High School 593 (54.4) 311 (57.1) 282 (51.5)
Relationship Status
 Single 414 (27.3) 199 (24.8) 215 (30.0) 0.073
 Co-habitation 790 (72.7) 401 (75.2) 389 (70.0)
Medicaid Enrollment
 Yes 678 (49.0) 315 (43.2) 363 (55.1) <0.001*
Maternal Race
 White/Other 717 (75.4) 377 (78.4) 340 (72.3) 0.011*
 African American 490 (24.6) 225 (21.6) 265 (27.7)
Parity
 Nulliparous 506 (41.8) 295 (49.5) 211 (33.7) <0.001*
Gestational Diabetes
 Yes 61 (5.4) 14 (2.3) 47 (8.8) <0.001*
Hypertensive Disorders
 None 1077 (90.1) 558 (93.8) 519 (87.0)
 Chronic Hypertension 44 (3.1) 16 (2.0) 28 (4.2) 0.003*
 Preeclampsia/Gestational HT 88 (6.4) 28 (4.2) 58 (8.7)
Gestational Smoking
 Any 337 (27.6) 164 (25.5) 173 (29.9) 0.157
Gestational Alcohol Use
 Any 204 (17.5) 108 (18.1) 96 (16.9) 0.296
Timing of Delivery
 Preterm 292 (10.7) 149 (10.8) 143 (10.7) 0.148
 Term 915 (89.3) 453 (89.2) 462 (89.3)
Child Gender






















 Male 615 (49.1) 313 (49.2) 302 (49.1) 0.972
BMI=Body mass index, GED=General education development examination, HT=hypertension.
*
Significant p-value <0.05 comparing pre-pregnancy BMI <25kg/m2 to pre-pregnancy BMI ≥25kg/m2.
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